Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
11/2005
11/10/2005DE102004019492A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
11/10/2005CA2564085A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
11/10/2005CA2563990A1 Thienopyridazines as ikk inhibitors
11/10/2005CA2563982A1 Thienopyridines as ikk inhibitors
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1592694A2 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
11/09/2005EP1592693A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
11/09/2005EP1427734B1 GLYCINE-SUBSTITUTED THIENO[2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP0918775B1 Phenyl-substituted cyclic ketoenol
11/08/2005US6963080 Thin film transistors using solution processed pentacene precursor as organic semiconductor
11/08/2005US6962939 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
11/08/2005US6962918 Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
11/03/2005WO2005103059A1 Clopidogrel salt and polymorphic forms thereof
11/03/2005WO2005103058A1 Polymorphic forms of methyl (+) - (s) -alpha- (2-chlorophenyl) -6, 7-dihydrothieno `3,2-c!pyridine-584h) acetate hydrobromide, clopidrogel hydrobromide
11/03/2005WO2005103039A1 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists
11/03/2005WO2005103037A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005US20050245565 Diamine derivatives
11/03/2005US20050245547 6-((6,7-Bis(methoxy)-4-quinolinyl)oxy)-N-(3-methylphenyl)-1-benzofuran-3-carboxamide;antiproliferative; -metastasis; -carcinogenic; -tumor; -inflammatory; -arthritic agents;hypotensive agents; myocardium necrosis; rheumatic diseases; tyrosine kinase inhibitors; antiallergens; asthma
11/03/2005US20050245505 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
11/03/2005US20050244807 Two-photon absorption heteroaromatic chromophores and compositions thereof
11/03/2005DE102004018796A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
11/03/2005CA2565219A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005CA2562507A1 Polymorphic forms of methyl(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h) acetate hydrobromide, clopidrogel hydrobromide
11/03/2005CA2561006A1 Clopidogrel salt and polymorphic forms thereof
11/02/2005EP1591446A1 Thienopyrimidine compounds and use thereof
11/02/2005EP1590352A1 4-AMINOTHIENO [2,3-d] PYRIMIDINE-6-CARBONITRILE DERIVATIVES AS PDE7 INHIBITORS
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1589970A2 Pharmaceutical compositions comprising thieno [2,3-c]pyridine deritives and use thereof
11/02/2005EP1589969A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/02/2005EP1080095B1 Modulators of protein tyrosine phosphatases (ptpases)
11/02/2005EP0929520B1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
11/02/2005CN1692108A Pesticidal heterocycles
11/02/2005CN1690060A Process for preparing I-clopidogrel hydrogen sulfate
11/01/2005US6960593 6,7-dihydro-5H-pyrazolo[1,2a]pyrazol-1-ones which control inflammatory cytokines
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960474 Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator
10/2005
10/27/2005WO2005100365A1 Thienopyridine derivatives
10/27/2005WO2005100364A1 Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form i
10/27/2005WO2005100355A1 Cyclic amine compound
10/27/2005WO2005100352A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005WO2005100343A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2004058704A8 Quinazolinones as potassium channel modulators
10/27/2005US20050240020 Functional fluorescent dyes
10/27/2005US20050240017 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss
10/27/2005US20050239899 Beta-secretase inhibitors
10/27/2005US20050239865 3-Cyano-2-amide-5,6-dihydrothieno[2,3-b]pyridine derivatives, e.g., tert-butyl 3-cyano-2-[(2-ethylbutanoyl)amino]-5,6-dihydrothieno[2,3-b]pyridine-7(4H) carboxylate; the compounds block the action of glucagon at its receptor and decrease the levels of plasma glucose to treat diabetes
10/27/2005US20050239794 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 4-(4-pyrimid-2-ylaminosulfonyl-1,4-phenylene-aminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
10/27/2005US20050239793 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
10/27/2005US20050239772 Condensation of molar excess of N-methylpiperazine with 4-amine-2-methyl-10H-thieno [2,3-b][1,5]benzodiazepine hydrochloride in dimethylsulfoxide; recovery and purification with methylene chloride
10/27/2005US20050239107 Trapped photochromes and thermochromes and uses for chromogenic detection, including detection of airborne contaminants
10/27/2005DE102004018795A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
10/27/2005CA2563386A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005CA2562827A1 Thienopyridine derivatives
10/27/2005CA2562526A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
10/27/2005CA2562406A1 Cyclic amine compound
10/26/2005EP1589089A1 Light-emitting device, condensed polycyclic compound used therein and method for producing same
10/26/2005EP1589019A1 Stereoselective process for the preparation of Clopidogrel
10/26/2005EP1589017A2 12,13-modified epothilone derivatives
10/26/2005EP1589006A1 Oxa- and thiazole derivatives useful as antidiabetics and antidiobesity agents
10/26/2005EP1587812A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease
10/26/2005EP1587811A1 Thienopyridazinones and their use in modulation of autoimmune disease
10/26/2005EP1587809A1 Novel compounds
10/26/2005EP1587807A2 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/26/2005CN1688588A Process and intermediates for the preparation of thienopyrrole derivatives
10/26/2005CN1688587A Process and intermediates for the preparation of the thienopyrrole derivatives
10/26/2005CN1688315A Use of selective COX-2 inhibitors for the treatment of urinary incontinence
10/20/2005WO2005097806A1 Compounds and methods for treating dyslipidemia
10/20/2005WO2005097805A1 Compounds and methods for treating dyslipidemia
10/20/2005WO2005097804A1 Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
10/20/2005WO2005097758A1 Certain triazole-based compounds, compositions, and uses thereof
10/20/2005WO2005097118A1 Aldosterone receptor antagonists
10/20/2005WO2005097107A2 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/20/2005WO2004071460A3 Cyclic derivatives as modulators of chemokine receptor activity
10/20/2005US20050234091 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-[4-(5-Fluoro-2-methoxyphenyl)-2-hydroxy-4-methyl-2-trifluoromethylpentyl]-4H-thieno[3,2-b]pyridin-7-one derivatives
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005CA2562399A1 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/20/2005CA2560954A1 Certain triazole-based compounds, compositions, and uses thereof
10/20/2005CA2557010A1 Compounds and methods for treating dyslipidemia
10/19/2005EP1586575A2 Salt of a sulfonic acid containing clopidogrel and use thereof for the preparation of pharmaceutical compositions
10/19/2005EP1586572A1 Fused pyrazolyls as anti-cancer drugs
10/19/2005EP1585728A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
10/19/2005EP1585522A2 Quinazolinones as potassium channel modulators
10/19/2005EP1337523B1 2,4-substituted pyridine derivatives
10/19/2005EP1246784B1 Reaction of carbonyl compounds with organometallic reagents
10/19/2005CN1683373A Thiophenopyridine substituted acetyl hyarazine derivative
10/19/2005CN1683336A Process for synthesizing acyl imidogen substituted cyclo compound
10/18/2005US6956035 Isoquinoline derivatives and methods of use thereof
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005CA2184386C Interference eliminating agent for application in immunoassays
10/13/2005WO2005095401A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
10/13/2005WO2005095387A1 Tricyclic pyrazole kinase inhibitors
10/13/2005WO2005095386A1 Substituted thiophene derivatives as anti-cancer agents
10/13/2005WO2005094833A1 Novel n-substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators
1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 214